Hummingbird Bioscience Announces Poster Presentation on HMBD-802, Novel Dual-Payload Antibody-Drug C
SAN FRANCISCO and SINGAPORE, Oct. 23, 2024 (GLOBE NEWSWIRE) - Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today announced a poster presentation on HMBD-802, a novel first-in-class dual-payload anti-HER2 antibody-drug conjugate, at the 36th EORTC-NCI-AACR symposium (23-25 October 2024).
“We are excited to present at EORTC-NCI-AACR with data demonstrating how HMBD-802 can potently treat tumors in T-DXd-insensitive settings whilst maintaining an optimal safety profile. I look forward to sharing more about its potential as a therapeutic option post and beyond T-DXd for HER2-positive cancers,” said Jerome Boyd-Kirkup, PhD, Chief Scientific Officer of Hummingbird Bioscience.
Poster details
Title: A novel HER2 targeted dual-payload ADC, HMBD-802, overcomes resistance to topoisomerase 1 inhibitor ADCs
Date: 24 October 2024
Location: Exhibition Hall
Session: Antibody-drug conjugates
Poster number: PB154
Abstract number: 166
About HMBD-802
HMBD-802 is a novel, first-in-class anti-HER2 dual-payload antibody-drug conjugate developed with Hummingbird Bioscience’s proprietary antibody and dual-payload ADC platform technologies. HMBD-802 allows targeted delivery of payloads to HER2-expressing tumors to maximize anti-tumor efficacy, overcome topoisomerase 1 inhibitor resistance, and reduce systemic toxicity.
About Hummingbird Bioscience
Hummingbird Bioscience is a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases. To address key challenges with current antibody-drug conjugate (ADC) therapies, Hummingbird Bioscience is building a pipeline of next-generation ADCs using its proprietary antibody discovery and linker/payload platforms. The company has a pipeline of ADCs in preclinical development and other novel biologics including monoclonal antibodies, HMBD-001 (anti-HER3 mAb) and HMBD-002 (anti-VISTA mAb) in Phase I and an out-licensed ADC (HMBD-501) that is slated for the clinic. The Hummingbird Bioscience approach combines computational and systems biology with wet lab drug discovery in a multi-disciplinary, collaborative environment spanning initial discovery through clinical development. The company harnesses this integrated approach across target identification and patient selection, enabling the team to increase the efficiency of translating novel scientific insights while reducing the inherent risk in drug discovery and development. At Hummingbird Bioscience, the commitment to rigorous science, teamwork, and intellectual integrity underpins our passion to accelerate the journey of new drugs from concept to clinic.
For more information, please visit www.hummingbirdbioscience.com, and follow Hummingbird Bioscience on LinkedIn, X (formerly Twitter), and YouTube.
Contacts
Media:
Crystal Ho
c.ho@hummingbirdbio.com
media@hummingbirdbio.com
+65 6979 5580
Investors:
investors@hummingbirdbio.com
- Teledyne FLIR IIS announces a new modular and compact USB3 machine vision camera series
- 临商银行北城支行营业部大力宣传反假币活动效果显著
- 芳纶新材料:开启未来之门
- 【上海绿色建博会资讯】“青春舱”热销背后是别墅业主的消费能力
- 税助制造业高新技术企业向“新”发展
- 天下网商联合长江商学院成功举办掘金“新型消费”沙龙,探寻品类王者的增长之道
- 探索PC控制技术的无限可能,中科时代推进国产替代新征程
- “天下贵州人”春天之约,茅恒来了,贵州酱酒再添骨干力量
- “重构烹饪全链路”:重构的不止烹饪生态,更有老板电器的未来
- 大湾区共同家园青年公益基金 携手中华厨艺学院 首办《岭南文化之凤城点心培训计划》
- C.K. McWhorter Calls For Hostage Release & Cease Fire in Gaza: An Official Proclamation of Peace
- 【广材试验机】惠州+茂名地导线卧式拉力试验机报价方案厂家
- 网球小将,营养先行:一米八助力青少年网球梦想
- 越捷航空2024年再度荣登“越南50强上市公司”榜单
- 贵州两山天麻集团:“数说天麻”,“两山论”的生动实践
- Zymeworks Announces Participation in Upcoming Investor Conferences
- 长治市屯留区“双招双引”人才基地 领航创新驱动战略新高地
- 临商银行商城小微支行“三点发力”打好反洗钱工作“组合拳”
- 老百姓维护自己的权yi真的这么难吗
- Kinaxis欢迎新的解决方案扩展合作伙伴PredictHQ
- 重磅!舒尔美携全系列产品惊艳亮相2024医博会
- “周天生物科技”致敬5·10中国品牌日签约中国人保责任险承保,为消费者保驾护航!
- 隽思集团2024年中期纯利升50.9%至5,400万港元
- Hitachi Energy to appoint Andreas Schierenbeck as new Chief Executive Officer, Claudio Facchin to st
- Therabody®携手上汽摩助力2024 F1中国大奖赛,见证车手驰骋赛场
- 阳光人寿开展“全国生态日”活动 守护绿色美好生活
- 要炸!西安绝版小户型来了!招商揽阅大城新作重磅登场!
- 以道谋势 成就卓越 ——解码我国新锐企业家领军人物农夫铺子创始人袁道红创业之道
- 农发行天镇县支行助力天镇县设施农业现代化
- Mavenir 5G Core Powers ice Norway Network Slicing for Norwegian Armed Forces
推荐
- 中国减排方案比西方更有优势 如今,人为造成的全球变暖是每个人都关注的问 资讯
- 奥运冠军刘翔更新社交账号晒出近照 时隔473天更新动态! 2月20日凌晨2点,奥运冠军刘翔更新社交账号晒 资讯
- 海南大学生返校机票贵 有什么好的解决办法吗? 近日,有网友在“人民网领导留言板&rdqu 资讯
- 中央气象台连发四则气象灾害预警 暴雪橙色预警+冰冻橙色预警+大雾黄色预警+ 资讯
- 私域反哺公域一周带火一家店! 三四线城市奶茶品牌茶尖尖两年时间做到GMV 资讯
- 男子“机闹”后航班取消,同机旅客准备集体起诉 1月4日,一男子大闹飞机致航班取消的新闻登上 资讯
- 产业数字化 为何需要一朵实体云? 改革开放前,国内供应链主要依靠指标拉动,其逻 资讯
- 看新东方创始人俞敏洪如何回应董宇辉新号分流的? (来源:中国证券报) 东方甄选净利润大幅下滑 资讯
- 一个“江浙沪人家的孩子已经不卷学习了”的新闻引发议论纷纷 星标★ 来源:桌子的生活观(ID:zzdshg) 没 资讯
- 抖音直播“新红人”进攻本地生活领域 不难看出,抖音本地生活正借由直播向本地生活 资讯